Filling a ‘crucial gap’ for new biotech ideas
District 3 also supports Hyasynth Bio, a biotechnology company that develops cultured yeast that mimics the effects of cannabinoids – all without the physical and psychological effects of marijuana.
Kevin Chen, CEO and co-founder of Hyasynth Bio, says that not having access to lab space prevents a lot of biotech startups from even getting started.
“District 3 made that happen for us and is filling that crucial gap for other new ideas in biotechnology, too,” he says. “On top of that, they’re still helping us make connections and grow our network locally and internationally.”
Read more about the Biolab and District 3’s commercialization program.